Goodwin Procter advised Manta Software in its acquisition by IBM. IBM acquired Manta Software Inc – a world-class data lineage platform — to complement its capabilities within...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Advanced Biologics in its merger with Isto Biologics. Isto Biologics, a portfolio company of TSCP and a global leader in regenerative and autologous...
You must be a Standard 1 Year member to access this content.
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
Goodwin advised Renesas Electronics Corporation, and Orrick advised Sequans. Renesas Electronics Corporation (TSE: 6723) and Sequans Communications S.A. (NYSE: SQNS) announced that the two companies have entered...
You must be a Standard 1 Year member to access this content.
Arnold & Porter advised Coherus Biosciences Inc. on the deal, and Goodwin advised Surface Oncology. Coherus Biosciences Inc. (Coherus) announced its acquisition of Surface Oncology Inc. (Surface),...
You must be a Standard 1 Year member to access this content.
Goodwin advised Bev on the deal. E. & J. Gallo Winery announced that it acquired Bev and its portfolio of premium canned wines and spritzers. The acquisition...
You must be a Standard 1 Year member to access this content.
Goodwin advised Honest Day’s Work on the deal. Latch, Inc. (NASDAQ: LTCH) announced that it has entered into a definitive agreement to acquire Honest Day’s Work...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Subject Matter, and Seyfarth Shaw advised Kivvit. Subject Matter, a portfolio company of Coral Tree Partners, announced its acquisition of Kivvit to create...
You must be a Standard 1 Year member to access this content.
Goodwin advised Education Growth Partners on its investment. Uwill announced it has completed a $30 million Series A funding round. The investment further cements Boston-based Uwill...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Weaviate.io on the deal. Weaviate.io announced its $50 million Series B funding round led by Index Ventures with participation from Battery Ventures. Weaviate’s existing...
You must be a Standard 1 Year member to access this content.
